Envision Financial Planning’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Envision Financial Planning's IBRX Position: Q3 2026 in Review
Envision Financial Planning held its ImmunityBio (IBRX) position steady in Q3 2026 at 10,450 shares worth $98.6K. The position accounts for 0.03% of the portfolio, ranked #53.
Envision Financial Planning first reported a position in IBRX in Q2 2025 and has held it in 6 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Envision Financial Planning held 10,450 shares of ImmunityBio worth $98.6K as of Q3 2026.
- Envision Financial Planning left its ImmunityBio share count unchanged in Q3 2026.
- ImmunityBio made up 0.03% of Envision Financial Planning's portfolio in Q3 2026, its #53 holding.
- Envision Financial Planning first reported a position in ImmunityBio in Q2 2025 and has held it in 6 quarters since.
- 405 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Envision Financial Planning's 13F filing for Q3 2026, filed 16 Nov 2026.